DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 190 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,208 | +30.6% | 81,806 | +14.3% | 0.01% | +50.0% |
| Q2 2023 | $925 | -8.9% | 71,574 | -30.8% | 0.01% | 0.0% |
| Q1 2023 | $1,015 | +686.8% | 103,443 | +754.9% | 0.01% | +300.0% |
| Q4 2022 | $129 | -100.0% | 12,100 | -92.1% | 0.00% | -90.5% |
| Q1 2022 | $1,667,000 | +526.7% | 153,758 | +468.5% | 0.02% | +600.0% |
| Q2 2021 | $266,000 | -64.3% | 27,045 | -64.3% | 0.00% | -72.7% |
| Q1 2021 | $745,000 | +244.9% | 75,739 | +51.3% | 0.01% | +175.0% |
| Q3 2020 | $216,000 | +28.6% | 50,048 | +70.5% | 0.00% | +33.3% |
| Q4 2019 | $168,000 | – | 29,346 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
| Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
| PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
| Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
| MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
| Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
| Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
| Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
| FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
| JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |